The pathogenesis of traumatic coagulopathy

Anaesthesia

Volumn 70, Issue s1, 2015, Pages 96-

  Cap, A ^a   Hunt, B J ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; BLOOD COAGULATION DISORDERS; COMPLICATION; HUMAN; INJURY; RESUSCITATION; THROMBOELASTOGRAPHY;

ACUTE DISEASE; BLOOD COAGULATION DISORDERS; HUMANS; RESUSCITATION; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 84925223999     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12914     Document Type: Review

References (91)

1. WHO. World Health Organisation. Global Health Indicators, 2011. http://www.who.int/whosis/whostat/EN_WHS2011_Part2.pdf (accessed 17/09/2014).
2. Eastridge BJ, Mabry RL, Seguin P, et al. Death on the battlefield (2001-2011): Implications for the future of combat casualty care. Journal of Trauma and Acute Care Surgery 2012; 73: S431-7.
3. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet J-F. Acute traumatic coagulopathy: Initiated by hypoperfusion: Modulated through the protein C pathway? Annals of Surgery 2007; 245: 812-8.
4. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. Journal of Trauma 2008; 64: 1211-7.
5. Davenport R, Manson J, De’Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Critical Care Medicine 2011; 39: 2652-8.
6. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute traumatic coagulopathy: Clinical and experimental investigations. Journal of Thrombosis and Haemostasis 2010; 8: 1919-25.
7. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. Journal of Trauma 2003; 54: 1127-30.
8. Valeri CR, Khuri S, Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: Role of temperature, red blood cells, platelets, and plasm-clotting proteins. Transfusion 2007; 47: S206-48.
9. Eugster M, Reinhart WH. The influence of the haematocrit on primary haemostasis in vitro. Thrombosis and Haemostasis 2005; 94: 1213-8.
10. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model. British Journal of Anaesthesia 2009; 102: 793-9.
11. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38: 298-304.
12. Hunt BJ, Jurd KM. Endothelial cell activation. British Medical Journal 1998; 316: 1328-9.
13. Johansson PI, Sorensen AM, Perner A, et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? A prospective observational study. Critical Care 2011; 15: R272.
14. Dirkmann D, Radu-Berlemann J, Görlinger K, Peters J. Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid. Journal of Trauma and Acute Care Surgery 2013; 74: 482-8.
15. Martini WZ, Pusateri AE, Uscilowicz JM, Delgado AV, Holcomb JB. Independent contributions of hypothermia and acidosis to coagulopathy in swine. Journal of Trauma 2005; 58: 1002-9.
16. Wolberg AS, Meng ZH, Monroe DM 3rd, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. Journal of Trauma 2004; 56: 1221-8.
17. Andre P, Srinivasa P, Denis CV, et al. CD40L stabalizes arterial thrombi by a beta3 integrin-dependent mechanism. Nature Medicine 2002; 8: 24752.
18. Johansson PI, Windeløv NA, Rasmussen LS, Sørensen AM, Ostrowski SR. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. Journal of Thrombosis and Haemostasis 2012; 10: 207-16.
19. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-7.
20. Johansson PI, Sørensen AM, Perner A, et al. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. Journal of Emergencies, Trauma and Shock 2013; 6: 171-5.
21. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: An on-scene and hospital admission study. Injury 2012; 43: 26-32.
22. Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. Journal of Trauma 2011; 71: S435-40.
23. Shaz BH, Winkler AM, James AB, Hillyer CD, MacLeod JB. Pathophysiology of early trauma-induced coagulopathy: Emerging evidence for hemodilution and coagulation factor depletion. Journal of Trauma 2011; 70: 1401-7.
24. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009; 49: 2652-60.
25. Chandler W. Procoagulant activity in trauma patients. American Journal of Clinical Pathology 2010; 134: 90-6.
26. Hayakawa M, Sawamura A, Gando S, et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery 2011; 149: 221-30.
27. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. Journal of Trauma 2003; 55: 39-44.
28. Yuan S, Ferrell C, Chandler WL. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thrombosis Research 2007; 120: 29-37.
29. Cohen MJ, Call M, Nelson M, et al. Critical role of activated Protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Annals of Surgery 2012; 255: 379-85.
30. Omar MN, Mann KG. Inactivation of factor Va by plasmin. Journal of Biological Chemistry 1987; 262: 9759-5.
31. Campbell JE, Meledeo MA, Cap AP. Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy. PLoS ONE 2014; 9: E99181.
32. Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. Journal of Biological Chemistry 2001; 276: 15567-70.
33. Cardenas JC, Rahbar E, Pommerening MJ, et al. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma. Journal of Trauma and Acute Care Surgery DOI: 10.1097/TA.0000000000000348.
34. Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor- 1. Journal of Thrombosis and Haemostasis 2005; 3: 35-45.
35. Griffin JH, Fern_andez JA, Gale AJ, Mosnier LO. Activated protein C. Journal of Thrombosis and Haemostasis 2007; 5: S73-80.
36. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
37. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101.
38. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Annals of Surgery 2010; 252: 434-42.
39. Levrat A, Gros A, Rugeri L, Floccard B, Negrier C, David J-S. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. British Journal of Anaesthesia 2008; 100: 792-7.
40. Sawamura A, Hayakawa M, Gando S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thrombosis Research 2009; 124: 608-13.
41. Schöchl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry. Journal of Trauma 2009; 67: 125-31.
42. Schöchl H, Nieaber U, Hofer G, et al. Goal-directed coagulation management of major trauma pateints using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Critical Care 2010; 14: R55.
43. Hunt BJ, Raza I, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients: A reply to a rebuttal. Journal of Thrombosis and Haemostasis 2013; 11: 1437-8.
44. Kushimoto S, Gando S, Saitoh D, et al. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma. Thrombosis and Hemostasis 2008; 100: 1099-105.
45. Chen JP, Rowe DW, Enderson BL. Contrasting post-traumatic serial changes for D-dimer amd PAI-1 in critically injured patients. Thrombosis Research 1998; 94: 175-85.
46. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. Journal of Hemostasis and Thrombosis 2007; 5: 289-95.
47. Nogami K, Shima M, Matsumoto T, Nishiya K, Tanaka I, Yoshioka A. Mechanism of plasmin-catalyzed inactivation of Factor VIII. Journal of Biological Chemistry 2007; 282: 5287-95.
48. Faller DV. Endothelial cell responses to hypoxic stress. Clinical and Experimental Pharmacology and Physiology 1999; 26: 74-84.
49. Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. Journal of Trauma 2008; 64: 1459-65.
50. Darlington DN, Craig T, Gonzales MD, Schwacha MG, Cap AP, Dubick MA. Acute coagulopathy of trauma in the rat. Shock 2013; 39: 440-6.
51. Pinksy DJ, Yan SF, Lawson C, et al. Hypoxia and modification of the endothelium: Implications for regulation of vascular homeostatic properties. Seminars in Cellular Biology 1995; 6: 283-94.
52. Komissarov AA, Andreasen PA, Declerck PJ, Kamikubo Y, Zhou A, Gruber A. Redirection of the reaction between activated protein C and a serpin to the substrate pathway. Thrombosis Research 2008; 122: 397-404.
53. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell and Tissue Research 2009; 335: 143-51.
54. Castellino FJ, Chapman MP, Donahue DL, et al. Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. Journal of Trauma and Acute Care Surgery 2014; 76: 1169-76.
55. Kutcher ME, Redick BJ, McCreery RC, et al. Characterization of platelet dysfunction after trauma. Journal of Trauma and Acute Care Surgery 2012; 73: 13-9.
56. Perkins JG, Cap AP, Spinella PC, et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. Journal of Trauma 2009; 66: S77-84.
57. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. American Journal of Surgery 2009; 197: 565-70.
58. Brown LM, Knudson MCohen MJ. Trauma Outcomes Group. A normal platelet count may not be enough: The impact of admission platelet count on mortality and transfusion in severely injured trauma patients. Journal of Trauma 2011; 71: S337-42.
59. Stansbury LG, Hess AS, Thompson K, Kramer B, Scalea TM, Hess JR. The clinical significance of platelet counts in the first 24 hours after severe injury. Transfusion 2013; 53: 783-9.
60. Inaba K, Branco BC, Rhee P, et al. Impact of the duration of platelet storage in critically ill trauma patients. Journal of Trauma 2011; 71: 1766-73.
61. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 2003; 197: 1585-98.
62. Morel N, Morel O, Petit L, et al. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. Journal of Trauma 2008; 64: 698-704.
63. Park MS, Owen BA, Ballinger BA, et al. Quantification of hypercoagulable state after blunt trauma: Microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery 2012; 151: 831-6.
64. Gando S, Sawamura A, Hayakawa M. Trauma, shock and disseminated intravascular coagulation: Lessons from the classical literature. Annals of Surgery 2011; 254: 10-9.
65. Rizoli S, Nascimento B, Key N, et al. Disseminated Intravascular Coagulopathy in the first 24 hours after trauma: The association between ISTH score and anatomopathologic evidence. Journal of Trauma 2011; 71: S441-7.
66. Maegele M, Lefering R, Wafaisade A, et al. Revalidation and update of the TASH-Score: A scoring system to predict the probability for massive transfusion as a surrogate for lifethreatening haemorrhage after severe injury. Vox Sanguinis 2011; 100: 231-8.
67. Cancio LC, Wade CE, West SA, Holcomb JB. Prediction of mortality and of the need for massive transfusion in casualties arriving at combat support hospitals in Iraq. Journal of Trauma 2008; 64: S51-6.
68. Ruchholtz S, Pehle B, Lewan U, et al. The emergency room transfusion score (ETS): Prediction of blood transfusion requirement in initial resuscitation after severe trauma. Transfusion Medicine 2006; 16: 49-56.
69. Schreiber MA, Perkins J, Kiraly L, Underwood S, Wade C, Holcomb JB. Early predictors of massive transfusion in combat casualties. Journal of the American College of Surgery 2007; 205: 541-5.
70. Yucel N, Lefering R, Maegele M, et al. Trauma associated severe hemorrhage (TASH)-score: Probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. Journal of Trauma 2006; 60: 1228-37.
71. Reed MJ, Lone N, Walsh TS. Resuscitation of the trauma patient: Tell me a trigger for early haemostatic resuscitation please!. Critical Care 2011; 15: 126.
72. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Current Hematology Reports 2004; 3: 324-30.
73. Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. Journal of Thrombosis and Haemostasis 2013; 11: 307-14.
74. Hunt BJ, Segal H. Hyperfibrinolysis. Journal of Clinical Pathology 1996; 49: 958.
75. Carroll RC, Craft RM, Langdon RJ, et al. Early evaluation of acute traumatic coagulopathy by thromboelastography. Translational Research 2009; 154: 34-9.
76. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Reviews 2009; 23: 231-40.
77. Perkins JG, Cap AP, Spinella PC, et al. 31st Combat Support Hospital Research Group. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients. Transfusion 2011; 51: 242-52.
78. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects the mortality in patients receiving massive transfusions at a combat support hospital. Journal of Trauma 2007; 63: 805-13.
79. Pidcoke HF, Aden JK, Mora AG, et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: Increased plasma and platelet use correlates with improved survival. Journal of Trauma and Acute Care Surgery 2012; 73: S445-52.
80. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: An updated European guideline. Critical Care 2013; 17: R76.
81. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. Journal of Thrombosis and Haemostasis 2012; 10: 1342-51.
82. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ. Rasmussen TE Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: Findings from the MATTERs II Study. Journal of the American Medical Association Surgery 2013; 148: 218-25.
83. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: The paradigm of plasma and platelets - a review of the current literature. Transfusion 2010; 50: 701-10.
84. Khan S, Brohi K, Chana M, et al. International Trauma Research Network (INTRN). Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. Journal of Trauma and Acute Care Surgery 2014; 76: 561-7; discussion 567-8.
85. Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: The surgeon’s perspective. American Society of Hematology Education Program 2013; 2013: 656-9.
86. Spinella PC, Reddy HL, Jaffe JS, Cap AP, Goodrich RP. Fresh whole blood use for hemorrhagic shock: Preserving benefit while avoiding complications. Anesthesia and Analgesia 2012; 115: 751-8.
87. Cotton BA, Podbielski J, Camp E, et al. Early Whole Blood Investigators. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Annals of Surgery 2013; 258: 527-32.
88. Murdock AD, Berseus O, Hervig T, Strandenes G, Lunde TH. Whole blood: The future of traumatic hemorrhagic shock resuscitation. Shock 2014; 41: 62-9.
89. Cap AP. The school of hard knocks: What we’ve learned and relearned about transfusion in a decade of global conflict. Transfusion Medicine 2014; 24: 135-7.
90. Coagulation management in trauma-related massive bleeding - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI). Anasthesiologie und Intensivmedizin Notfallmed Schmerzther 2010; 45: 552-61.
91. Schöchl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: A 7-day observational study of trauma patients. Critical Care 2014; 18: R147.